Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Keros Therapeutics, Inc. | 80,000 | reported | 24 Feb 2026 | tx 3+160,000−4,745 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Feb 2026 | GRANT_AWARD | Keros Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
| 18 Feb 2026 | SALE | Keros Therapeutics, Inc. | 4,745 | 16.35 USD |